Consuela A. Albright: The Critical Role of Black Blood Donors in Sickle Cell Treatment
Consuela A. Albright, Nurse Practitioner at Cleveland Clinic, shared a post on LinkedIn:
“Here’s a number worth sitting with: blood donors who are Black are almost three times more likely to be a close match for sickle cell patients than donors who aren’t – and that match quality matters enormously for people who need regular transfusions.
The American Red Cross Sickle Cell Initiative, launched in 2021, was built to close that gap.
Since launching, it has inspired more than 140,000 first-time African American blood donors, provided over 300,000 free sickle cell trait screenings to donors who self-identify as Black or multiracial, and invested over $200,000 in scholarships for high schoolers committed to supporting the sickle cell community.
Every September, the initiative expands its reach through partnerships with HBCUs, the National Pan-Hellenic Council, Inc., and organizations like the NAACP and 100 Black Men of America, Inc.
This is advocacy you can act on today, not just something to read about.
If you’re eligible, a single donation appointment is a direct, measurable contribution to someone’s sickle cell care.”
Stay updated with Hemostasis Today.
-
Nov 11, 2026, 13:46Danny Gaskin: Recognising Iron Deficiency Before Anaemia
-
Nov 11, 2026, 13:46James P. Crowley: Newborn Vitamin K Refusal a 347% Surge in Life-Threatening Bleeding
-
Nov 11, 2026, 13:42Manideepa Maji: IV Iron Safety in Heart Failure
-
Nov 11, 2026, 13:36Wilson Andrés Vásconez Samaniego: NGS-Based Genomic Profiling Before Gene Therapy for Hemoglobinopathies
-
Nov 11, 2026, 13:34Mathieu Jackson: WFH Opens Registration for 2027 Comprehensive Care Summit
-
Nov 11, 2026, 13:29Maia Meier: Recognising Bleeding Disorders Through the 7-2-1 Rule
-
Nov 11, 2026, 13:17Kiran Rajeev T: Elsevier Releases New Practical Handbook on Transfusion Medicine
-
Nov 11, 2026, 13:01Reza Shojaei: FDA Approval Marks Milestone for Factor XIa-Targeted Therapy
-
Nov 11, 2026, 11:35Paulus Kirchhof: Oral Anticoagulation in Atrial Fibrillation After Intracranial Hemorrhage